OOIR: Observatory of International Research

Papers

(The H4-Index of Harm Reduction Journal is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Expanding single-venue services to better engage young people who inject drugs: insights from India	78
Nasal administration of diacetylmorphine improved the adherence in a patient receiving heroin-assisted treatment	64
The acceptability of overdose alert and response technologies: introducing the TPOM-ODART framework	53
Acceptability of supervised injection facilities among persons who inject drugs in upstate New York	52
Experiences of harm and mental ill-health among gay, bisexual and other men-who-have-sex-with-men who use methamphetamine or GHB/GBL in different combinations: findings from the COMeT study in Taiwan	48
Associations with experience of non-fatal opioid overdose in British Columbia, Canada: a repeated cross sectional survey study	47
Moving from ‘stigma reduction’ to ‘inclusion’: development of the inclusion collaborative at Nepean Blue Mountains Local Health District, New South Wales	44
The impact of institutionalization on the effectiveness of harm reduction: a qualitative study using drug users’ representations	42
“The people who depended on us became expendable”: Experiences of frontline workers with lived and living expertise of drug use during the COVID-19 pandemic	41
HIV risk and prevention among clients of a delivery-based harm reduction service during an HIV outbreak among people who use drugs in northern rural Minnesota, USA	41
Welfare first: transforming harm reduction at UK festivals	40
Contamination of a drug consumption room with drugs and potential risks for social health care workers	39
Drug decriminalization: a co-designed study outlining the implications for providers of youth services	38
Egocentric network characteristics of people who inject drugs in the Chicago metro area and associations with hepatitis C virus and injection risk behavior	38
Examining rural community pharmacists’ knowledge and practices in opioid overdose prevention and treatment services in the Southeastern United States	37
Exploring perceived quality of life in long-term methadone-dependent patients: a qualitative study	34
Willingness to use and distribute HIV self-testing kits among people who inject drugs in the San Diego–Tijuana border region	33
A mixed-methods analysis of risk-reduction strategies adopted by syringe services program participants and non-syringe services program participants in New York City	32
Decentralized HIV testing: comparing peer and mail-based distribution strategies to improve the reach of HIV self-testing among people who use drugs in Florida	32
Assessment of two brands of fentanyl test strips with 251 synthetic opioids reveals “blind spots” in detection capabilities	31
Fentanyl harm reduction strategies among Latinx communities in the United States: a scoping review	30
Barriers to uptake of harm reduction techniques for GBMSM who use drugs in night-clubs and sex-on-premises venues in London and the Southeast: a mixed-methods, qualitative study	29
Harm reduction in substance use: perspectives and experiences of community volunteers and student interns in Durban, South Africa	29
“Expected to happen”: perspectives on post-release overdose from recently incarcerated people with opioid use disorder	28
“To not feel fake, it can’t be fake”: co-creation of a harm reduction, peer-delivered, health-system intervention for people who use drugs	28

Is fentanyl in everything? Examining the unexpected occurrence of illicit opioids in British Columbia’s drug supply	28
Houselessness and syringe service program utilization among people who inject drugs in eight rural areas across the USA: a cross-sectional analysis	28
Vaping among Norwegians who smoke or formerly smoked: reasons, patterns of use, and smoking cessation activity	28
Improving access to HIV care among people who inject drugs through tele-harm reduction: a qualitative analysis of perceived discrimination and stigma	28
“Naloxone? Not for me!” First cross-assessment by patients and healthcare professionals of the risk of opioid overdose	28